lululemon athletica inc.
LULUNasdaqConsumer Discretionary · Apparel & Other Finishd Prods of Fabrics & Similar Matl · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|---|
| Revenue | $11.10B | $10.59B | $9.62B | $8.11B | $6.26B | $4.40B |
| Operating income | $2.21B | $2.51B | $2.13B | $1.33B | $1.33B | $820.0M |
| Net income | $1.58B | $1.81B | $1.55B | $854.8M | $975.3M | $588.9M |
| Total assets | $8.46B | $7.60B | $7.09B | $5.61B | $4.94B | $4.19B |
| Total liabilities | $3.49B | $3.28B | $2.86B | $2.46B | $2.20B | $1.63B |
| Equity | $4.96B | $4.32B | $4.23B | $3.15B | $2.74B | $2.56B |
| EPS (diluted) | $13.26 | $14.64 | $12.20 | $6.68 | $7.49 | $4.50 |
| Shares out. | 110.5M | 115.5M | 120.9M | 122.0M | 122.7M | 125.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 19.9%
- Net margin
- 14.2%
- Return on equity
- 31.8%
- Return on assets
- 18.7%
- Return on capital (ROCE)
- 33.7%
- Liabilities / assets
- 41.3%
- Debt / equity
- 0.70×
- Book value / share
- $44.91
- Revenue growth (YoY)
- 4.9%
- Net income growth (YoY)
- −13.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- 6.83safe
- Accruals / assets
- −0.3%clean
- Beneish M-Score
- -1.92normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 7 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Wilson Dennis J.Activist (13D)May 28, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 28, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Lipo Investments (Usa) Inc.Activist (13D)Dec 15, 2025
- Susquehanna Securities, LlcPassive (13G)Nov 13, 2025
- Fmr LlcPassive (13G)Oct 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Neuburger NicoleOfficer — Chief Brand Officer | Apr 8, 2026 | Sell | 622 | $161.00 |
| Maestrini AndreOfficer — Pres, CCO & Interim Co-CEO | Apr 1, 2026 | Buy | 3,275 | $151.02 |
| Frank MeghanOfficer — CFO & Interim Co-CEO | Mar 31, 2026 | Tax withholding | 400 | $153.10 |
| Neuburger NicoleOfficer — Chief Brand Officer | Mar 31, 2026 | Tax withholding | 369 | $153.10 |
| Maestrini AndreOfficer — Pres, CCO & Interim Co-CEO | Mar 31, 2026 | Tax withholding | 357 | $153.10 |
| Maestrini AndreOfficer — Pres, CCO & Interim Co-CEO | Mar 30, 2026 | Option exercise | 4,692 | $0.00 |
| Neuburger NicoleOfficer — Chief Brand Officer | Mar 30, 2026 | Option exercise | 3,754 | $0.00 |
| Frank MeghanOfficer — CFO & Interim Co-CEO | Mar 30, 2026 | Option exercise | 3,754 | $0.00 |
| Frank MeghanOfficer — CFO & Interim Co-CEO | Mar 25, 2026 | Tax withholding | 246 | $158.72 |
| Maestrini AndreOfficer — Pres, CCO & Interim Co-CEO | Mar 25, 2026 | Tax withholding | 220 | $158.72 |
| Neuburger NicoleOfficer — Chief Brand Officer | Mar 25, 2026 | Tax withholding | 224 | $158.72 |
| Mussafer David MDirector | Mar 19, 2026 | Grant | 1,087 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 6.3M | 1.9 | +14.4% |
| Apr 30, 2026 | 5.5M | 1.6 | +22.2% |
| Apr 15, 2026 | 4.5M | 2.3 | +0.2% |
| Mar 31, 2026 | 4.5M | 1.2 | -3.9% |
| Mar 13, 2026 | 4.7M | 1.8 | +4.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Regulation FD disclosureMay 27, 2026
- Director / officer change · Regulation FD disclosureApr 28, 2026
- Director / officer change · Regulation FD disclosureApr 22, 2026
- Results of operationsMar 17, 2026
- Director / officer change · Regulation FD disclosureMar 17, 2026
- Regulation FD disclosureJan 12, 2026
- Other material eventDec 29, 2025
- Results of operations · Director / officer change · Other material eventDec 11, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13D/AMay 28, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 27, 2026
- 8-KCURRENT REPORTMay 27, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 22, 2026
- DFAN14AMay 21, 2026
- SCHEDULE 13D/AMay 20, 2026
- DFAN14AMay 19, 2026
- DFAN14AMay 19, 2026
- DFAN14AMay 18, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 18, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 18, 2026
- ARSFORM ARSMay 18, 2026
- DEFC14APROXY STATEMENTMay 18, 2026
- DFAN14AMay 11, 2026
- SCHEDULE 13D/AMay 8, 2026